Summary
A DRUG company scheduled to supply one in every six flu vaccines for this year's immunisation campaign had its manufacturing licence withdrawn yesterday.
The Medicines and Health products Regulatory Agency (MHRA) said it had suspended Chiron's licence for three months with immediate effect, citing manufacturing problems.See the full content of this document
Extract
Flu Vaccine Firm Loses Its Licence to Manufacture Over Sterility Problem
The move had been anticipated for some time afte...
See the full content of this document

